Manufacturers Life Insurance Company, The Vaxart, Inc. Transaction History

Manufacturers Life Insurance Company, The

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.6 - $1.41 $29,718 - $69,838	-49,531 Closed	0 $0
Q4 2022 Aug 11, 2023	BUY	$0.75 - $2.24 $188 - $562	251 Added 0.51%	49,531 $47,000
Q4 2022 Feb 13, 2023	BUY	$0.75 - $2.24 $188 - $562	251 Added 0.51%	49,531 $47,000
Q3 2022 Aug 11, 2023	SELL	$2.09 - $4.5 $2,748 - $5,917	-1,315 Reduced 2.6%	49,280 $107,000
Q3 2022 Nov 03, 2022	SELL	$2.09 - $4.5 $2,748 - $5,917	-1,315 Reduced 2.6%	49,280 $107,000
Q2 2022 Aug 11, 2023	BUY	$2.7 - $5.28 $1,082 - $2,117	401 Added 0.8%	50,595 $177,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $5.28 $1,082 - $2,117	401 Added 0.8%	50,595 $177,000
Q1 2022 Aug 11, 2023	BUY	$4.29 - $6.64 $2,844 - $4,402	663 Added 1.34%	50,194 $252,000
Q1 2022 May 20, 2022	SELL	$4.29 - $6.64 $54,547 - $84,427	-12,715 Reduced 20.21%	50,194 $253,000
Q4 2021 Feb 16, 2022	BUY	$5.77 - $7.96 $4,038 - $5,572	700 Added 1.13%	62,909 $394,000
Q3 2021 Nov 12, 2021	SELL	$6.67 - $9.8 $34,210 - $50,264	-5,129 Reduced 7.62%	62,209 $495,000
Q2 2021 Aug 12, 2021	BUY	$5.06 - $10.78 $184,300 - $392,639	36,423 Added 117.82%	67,338 $504,000
Q1 2021 May 03, 2021	SELL	$5.64 - $23.33 $8,397 - $34,738	-1,489 Reduced 4.6%	30,915 $187,000
Q4 2020 Feb 12, 2021	BUY	$3.5 - $7.98 $7,759 - $17,691	2,217 Added 7.34%	32,404 $185,000
Q3 2020 Nov 09, 2020	BUY	$4.78 - $16.97 $14,363 - $50,994	3,005 Added 11.06%	30,187 $201,000
Q2 2020 Aug 10, 2020	BUY	$1.68 - $8.85 $45,665 - $240,560	27,182 New	27,182 $204,000

108

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $99.9M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.